End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression

BACKGROUND: The molecular mechanisms underlying chronic kidney disease (CKD) transition to end-stage renal disease (ESRD) and CKD acceleration of cardiovascular and other tissue inflammations remain poorly determined. METHODS: We conducted a comprehensive data analyses on 7 microarray datasets in pe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Redox Biol
Main Authors: Zhang, Ruijing, Saredy, Jason, Shao, Ying, Yao, Tian, Liu, Lu, Saaoud, Fatma, Yang, William Y., Sun, Yu, Johnson, Candice, Drummer, Charles, Fu, Hangfei, Lu, Yifan, Xu, Keman, Liu, Ming, Wang, Jirong, Cutler, Elizabeth, Yu, Daohai, Jiang, Xiaohua, Li, Yafeng, Li, Rongshan, Wang, Lihua, Choi, Eric T., Wang, Hong, Yang, Xiaofeng
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Articles from the Special Issue on Redox Signalling and Cardiovascular Disease; Edited by Christopher Kevil and Yabing Chen
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327976/
https://ncbi.nlm.nih.gov/pubmed/32179051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2020.101460
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados